Jan ter Meulen
Infectious Diseases
Crucell Holland BV
P.O. Box 2048
2301, CA Leiden
Netherlands
Name/email consistency: high
- Monoclonal antibodies for prophylaxis and therapy of infectious diseases. ter Meulen, J. Expert. Opin. Emerg. Drugs (2007)
- Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. ter Meulen, J., van den Brink, E.N., Poon, L.L., Marissen, W.E., Leung, C.S., Cox, F., Cheung, C.Y., Bakker, A.Q., Bogaards, J.A., van Deventer, E., Preiser, W., Doerr, H.W., Chow, V.T., de Kruif, J., Peiris, J.S., Goudsmit, J. PLoS Med. (2006)
- Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Meulen, J., Badusche, M., Satoguina, J., Strecker, T., Lenz, O., Loeliger, C., Sakho, M., Koulemou, K., Koivogui, L., Hoerauf, A. Virology (2004)
- Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. ter Meulen, J., Bakker, A.B., van den Brink, E.N., Weverling, G.J., Martina, B.E., Haagmans, B.L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W., Gelderblom, H.R., Goudsmit, J., Osterhaus, A.D. Lancet (2004)
- Activation of the cytokine network and unfavorable outcome in patients with yellow fever. ter Meulen, J., Sakho, M., Koulemou, K., Magassouba, N., Bah, A., Preiser, W., Daffis, S., Klewitz, C., Bae, H.G., Niedrig, M., Zeller, H., Heinzel-Gutenbrunner, M., Koivogui, L., Kaufmann, A. J. Infect. Dis. (2004)
